SPONSOR
ITM Oncologics GmbH
Total Trials
1
Recruiting
1
Phases
Phase 1, Phase 2
Conditions studied: Clear Cell Renal Cell Cancer (ccRCC)Pancreatic Ductal Adenocarcinoma (PDAC)Colorectal Cancer (CRC)Urothelial Carcinoma (UC)Indeterminate Renal Mass (IDRM)Muscle Invasive Bladder Cancer (MIBC)Head and Neck Cancer (H&N)Triple Negative Breast Cancer (TNBC)Squamous Non-Small Cell Lung Cancer (NSCLC)
ITM Oncologics GmbH is a clinical research sponsor with 1 registered studies on ClinicalTrials.gov, of which 1 are actively recruiting participants. Research covers conditions including Clear Cell Renal Cell Cancer (ccRCC), Pancreatic Ductal Adenocarcinoma (PDAC), Colorectal Cancer (CRC), Urothelial Carcinoma (UC).
The trial portfolio spans Phase 1, Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — ITM Oncologics GmbH
How many clinical trials has ITM Oncologics GmbH sponsored?
ClinicalMetric currently tracks 1 clinical trials sponsored by ITM Oncologics GmbH, of which 1 are actively recruiting participants. These trials cover conditions including Clear Cell Renal Cell Cancer (ccRCC), Pancreatic Ductal Adenocarcinoma (PDAC), Colorectal Cancer (CRC). Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does ITM Oncologics GmbH research focus on?
ITM Oncologics GmbH clinical trials span Clear Cell Renal Cell Cancer (ccRCC), Pancreatic Ductal Adenocarcinoma (PDAC), Colorectal Cancer (CRC), Urothelial Carcinoma (UC), Indeterminate Renal Mass (IDRM), and additional conditions. The research pipeline includes Phase 1, Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a ITM Oncologics GmbH clinical trial?
To participate in a ITM Oncologics GmbH trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all ITM Oncologics GmbH trials with current recruitment status updated daily.
Clinical Trials by ITM Oncologics GmbH
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology